Načítá se...
MVA85A vaccine to enhance BCG for preventing tuberculosis
BACKGROUND: Tuberculosis causes more deaths than any other infectious disease globally. Bacillus Calmette‐Guérin (BCG) is the only available vaccine, but protection is incomplete and variable. The modified Vaccinia Ankara virus expressing antigen 85A (MVA85A) is a viral vector vaccine produced to pr...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2019
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6488980/ https://ncbi.nlm.nih.gov/pubmed/31038197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012915.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|